eye problems with tirzepatide Complications from Semaglutide and Our vitreoretinal surgeon explains what

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, but concerns about tirzepatide and thyroid nodules have emerged from animal studies showing thyroid C-cell tumors in rodents

This wildly popular drug is a synthetic form of GLP-1 (glucagon-like peptide-1), a hormone that regulates blood sugar and curbs appetite

These effects combine to create a caloric deficit that leads to weight loss

Last Updated On 18 Aug

Even if theoretical highest dose of 20 mg is provided, at the end of 24 hrs, the amount of GHK-Cu remaining will be 20 /4096 = 0.0048 mg = 4.8 meg

Schiavon CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, Torreglosa CR, Bueno PT, et al